📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vivus

1.1 - Company Overview

Vivus Logo

Vivus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of next-generation therapeutic products, including QSYMIA, a once-daily oral medication for weight management that has shown to reduce blood pressure; PANCREAZE, a pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency (EPI); STENDRA, approved for erectile dysfunction; and VI-0106, a lead pipeline program for pulmonary arterial hypertension.

Products and services

  • QSYMIA: A once-daily oral medication for weight management that has shown to reduce blood pressure, from VIVUS, Inc., a drug-development company dedicated to next-generation therapeutic products
  • STENDRA: A medication approved for the treatment of erectile dysfunction from VIVUS, Inc., a drug-development company dedicated to next-generation therapeutic products
  • PANCREAZE: A pancreatic enzyme replacement therapy used to manage exocrine pancreatic insufficiency (EPI) from VIVUS, Inc., a drug-development company dedicated to next-generation therapeutic products

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vivus

RejuvenAir Logo

RejuvenAir

HQ: United States Website
  • Description: Provider of spray cryotherapy medical device solutions, offering the RejuvenAir System to deliver precise liquid nitrogen doses to targeted areas in the lungs to ablate damaged cells and treat chronic bronchitis; the Metered CryoSpray (MCS) technique for controlled delivery to reduce mucus over-production and promote regrowth of healthy airway cells; and the SPRAY-CB clinical trial evaluating effectiveness in COPD with chronic bronchitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RejuvenAir company profile →
Aerocrine Logo

Aerocrine

HQ: Sweden Website
  • Description: Provider of medical technology focused on improving treatment of patients with inflamed airways, emphasizing measurement of airway inflammation to help doctors diagnose, monitor, and optimize therapy for inflammatory airway diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aerocrine company profile →
Allied Healthcare Products Logo

Allied Healthcare Products

HQ: United States Website
  • Description: Provider of respiratory care products and medical gas equipment through manufacturing, marketing, and distribution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allied Healthcare Products company profile →
Aerin Medical Logo

Aerin Medical

HQ: United States Website
  • Description: Provider of therapeutic devices to improve nasal breathing, including RhinAer for treating chronic rhinitis symptoms—runny nose, post-nasal drip, and sneezing—by disrupting posterior nasal nerves, and VivAer for treating nasal airway obstruction via soft-tissue coagulation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aerin Medical company profile →
CardioDigital Logo

CardioDigital

HQ: Germany Website
  • Description: Provider of time-frequency-based analysis methods for medical signal analysis, monitoring, and prediction, with products including COP, a metric for cardioversion outcome prediction to aid clinical decision-making, and PlethRESP, which enables detection of respiration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CardioDigital company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vivus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vivus

2.2 - Growth funds investing in similar companies to Vivus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vivus

4.2 - Public trading comparable groups for Vivus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vivus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vivus

What does Vivus do?

Vivus is a provider of next-generation therapeutic products, including QSYMIA, a once-daily oral medication for weight management that has shown to reduce blood pressure; PANCREAZE, a pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency (EPI); STENDRA, approved for erectile dysfunction; and VI-0106, a lead pipeline program for pulmonary arterial hypertension.

Who are Vivus's competitors?

Vivus's competitors and similar companies include RejuvenAir, Aerocrine, Allied Healthcare Products, Aerin Medical, and CardioDigital.

Where is Vivus headquartered?

Vivus is headquartered in United States.

How many employees does Vivus have?

Vivus has 1,000 employees 🔒.

When was Vivus founded?

Vivus was founded in 2010 🔒.

What sector and industry vertical is Vivus in?

Vivus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vivus

Who are the top strategic acquirers in Vivus's sector and industry

Top strategic M&A buyers and acquirers in Vivus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vivus?

Top strategic M&A buyers groups and sectors for Vivus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vivus's sector and industry vertical

Which are the top PE firms investing in Vivus's sector and industry vertical?

Top PE firms investing in Vivus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vivus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vivus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vivus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vivus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vivus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vivus?

The key public trading comparables and valuation benchmarks for Vivus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vivus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vivus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vivus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vivus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vivus's' sector and industry vertical?

Access recent funding rounds and capital raises in Vivus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vivus